Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway

miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases

(2013) Sumiyo Morita et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Overexpressed MicroRNA-182 Promotes Proliferation and Invasion in Prostate Cancer PC-3 Cells by Down-Regulating N-myc Downstream Regulated Gene 1 (NDRG1)

(2013) Ranlu Liu et al.   PLoS One

miR-379 Regulates Cyclin B1 Expression and Is Decreased in Breast Cancer

(2013) Sonja Khan et al.   PLoS One

miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development

(2013) W Wei et al.   Cell Death & Disease

Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways

(2012) Shunsuke Noguchi et al.   CANCER LETTERS

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer

(2012) Sheng Wang et al.   Diagnostic Pathology

MiR-29 mediates TGFβ1-induced extracellular matrix synthesis through activation of PI3K-AKT pathway in human lung fibroblasts

(2012) Tao Yang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma

(2012) Lihua Li et al.   LABORATORY INVESTIGATION

Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma

(2011) Tung Nguyen et al.   Epigenetics

Chemotherapy in advanced bladder cancer: current status and future

(2011) Nabil Ismaili et al.   Journal of Hematology & Oncology

Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29

(2011) Yang Li et al.   JOURNAL OF PATHOLOGY

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma

(2011) Joana Heinzelmann et al.   WORLD JOURNAL OF UROLOGY

Epithelial-mesenchymal transition in breast cancer progression and metastasis

(2011) Yifan Wang et al.   Chinese Journal of Cancer

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

(2010) J.-J. Zhao et al.   BLOOD

Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways

(2010) Hervé Wallerand et al.   CURRENT OPINION IN UROLOGY

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

(2010) María Ángeles Castilla et al.   JOURNAL OF PATHOLOGY

Theranostic and prognostic biomarkers: genomic applications in urological malignancies

(2010) George J. Netto et al.   PATHOLOGY

MicroRNA 29b functions in acute myeloid leukemia

(2009) R. Garzon et al.   BLOOD

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer

(2009) Margaret A. Knowles et al.   CANCER AND METASTASIS REVIEWS

Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

(2009) L. Dyrskjot et al.   CANCER RESEARCH

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

miR-29 miRNAs activate p53 by targeting p85α and CDC42

(2008) Seong-Yeon Park et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY